Related references
Note: Only part of the references are listed.Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate
Stephen M. Stahl
CNS SPECTRUMS (2018)
An update on the advancements in the treatment of agitation in Alzheimer's disease
Anton P. Porsteinsson et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
Mechanism of action of brexpiprazole: comparison with aripiprazole
Stephen M. Stahl
CNS SPECTRUMS (2016)
Mechanism of action of pimavanserin in Parkinson's disease psychosis: targeting serotonin 5HT2A and 5HT2C receptors
Stephen M. Stahl
CNS SPECTRUMS (2016)
Dextromethorphan-quinidine-responsive pseudobulbar affect (PBA): psychopharmacological model for wide-ranging disorders of emotional expression?
Stephen M. Stahl
CNS SPECTRUMS (2016)
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients
Francesco Panza et al.
EXPERT OPINION ON EMERGING DRUGS (2016)
Deconstructing violence as a medical syndrome: mapping psychotic, impulsive, and predatory subtypes to malfunctioning brain circuits
Stephen M. Stahl
CNS SPECTRUMS (2014)
California State Hospital Violence Assessment and Treatment (Cal-VAT) guidelines
Stephen M. Stahl et al.
CNS SPECTRUMS (2014)
Mechanism of action of dextromethorphan/quinidine: comparison with ketamine
Stephen M. Stahl
CNS SPECTRUMS (2013)
Share Paper
